BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11949964)

  • 21. Selective progesterone receptor modulators: an update.
    Benagiano G; Bastianelli C; Farris M; Brosens I
    Expert Opin Pharmacother; 2014 Jul; 15(10):1403-15. PubMed ID: 24787486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective steroid receptor modulators in reproductive medicine.
    Giannini A; Russo E; Mannella P; Simoncini T
    Minerva Ginecol; 2015 Oct; 67(5):431-55. PubMed ID: 26200398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent patent trends in the field of progesterone receptor agonists and modulators.
    Schmees N; Weinmann H
    Expert Opin Ther Pat; 2009 Nov; 19(11):1521-34. PubMed ID: 19785507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New medical treatments for endometriosis.
    Olive DL; Lindheim SR; Pritts EA
    Best Pract Res Clin Obstet Gynaecol; 2004 Apr; 18(2):319-28. PubMed ID: 15157645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endometriosis in Italy: from cost estimates to new medical treatment.
    Luisi S; Lazzeri L; Ciani V; Petraglia F
    Gynecol Endocrinol; 2009 Nov; 25(11):734-40. PubMed ID: 19908951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progesterone receptor modulators and progesterone antagonists in women's health.
    Spitz IM; Chwalisz K
    Steroids; 2000; 65(10-11):807-15. PubMed ID: 11108892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progesterone receptor antagonists and the endometrial antiproliferative effect.
    Brenner RM; Slayden OD
    Semin Reprod Med; 2005 Feb; 23(1):74-81. PubMed ID: 15714391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis.
    Grandi G; Mueller MD; Papadia A; Kocbek V; Bersinger NA; Petraglia F; Cagnacci A; McKinnon B
    J Reprod Immunol; 2016 Sep; 117():30-8. PubMed ID: 27371899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
    Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
    Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal therapy for endometriosis: from molecular research to bedside.
    Tosti C; Biscione A; Morgante G; Bifulco G; Luisi S; Petraglia F
    Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():61-66. PubMed ID: 27503693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New medical treatments for painful endometriosis: CNGOF-HAS Endometriosis Guidelines].
    Legendre G; Delbos L; Hudon E; Chabbert-Buffet N; Geoffron S; Sauvan M; Fernandez H; Bouet PE; Descamps P
    Gynecol Obstet Fertil Senol; 2018 Mar; 46(3):256-263. PubMed ID: 29530558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications.
    Chabbert-Buffet N; Meduri G; Bouchard P; Spitz IM
    Hum Reprod Update; 2005; 11(3):293-307. PubMed ID: 15790602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonsteroidal progesterone receptor modulators: structure activity relationships.
    Winneker RC; Fensome A; Wrobel JE; Zhang Z; Zhang P
    Semin Reprod Med; 2005 Feb; 23(1):46-57. PubMed ID: 15714389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Down-regulation of endometrial matrix metalloproteinase-3 and -7 expression in vitro and therapeutic regression of experimental endometriosis in vivo by a novel nonsteroidal progesterone receptor agonist, tanaproget.
    Bruner-Tran KL; Zhang Z; Eisenberg E; Winneker RC; Osteen KG
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1554-60. PubMed ID: 16418212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging drugs for endometriosis.
    Fedele L; Berlanda N
    Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of action and clinical effects of antiprogestins on the non-pregnant uterus.
    Spitz IM; Robbins A
    Hum Reprod Update; 1998; 4(5):584-93. PubMed ID: 10027612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endometriosis: in search of optimal treatment.
    Nothnick WB
    Minerva Ginecol; 2010 Feb; 62(1):17-31. PubMed ID: 20186112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of antiprogestins on the uterus.
    Ouzounian S; Bouchard P; Chabbert-Buffet N
    Womens Health (Lond); 2008 May; 4(3):269-80. PubMed ID: 19072476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in the medical treatment of adolescent endometriosis.
    Yang L; Yu J; Zhang S; Zhang J
    Minerva Pediatr (Torino); 2023 Jun; 75(3):423-431. PubMed ID: 34309341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New drugs in development for the treatment of endometriosis.
    Fedele L; Somigliana E; Frontino G; Benaglia L; Vigano P
    Expert Opin Investig Drugs; 2008 Aug; 17(8):1187-202. PubMed ID: 18616415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.